Adaptogenics acquires nutritional research assets for GLP-1 initiative
Adaptogenics Health Corp. said it acquired nutritional research assets to support evidence-based products and future peptide programs for patients using GLP-1 therapies.
Adaptogenics Health Corp. said it has acquired a research platform to support evidence-based products and future peptide programs for patients using GLP-1 therapies. The company said the transaction was announced in Vancouver, British Columbia, on October 8, 2026.